Developers
Yanzhen Li, Sophie
Description of the technology
The technology has been created in the frameworks of the improvement of reprogramming process of neonatal cardiac fibroblasts into cells of myocardium. Recently the authors of this technology found that a combination of microRNAs, miR combo, can directly reprogram cardiac fibroblasts into functional cardiomyocytes in vitro and in vivo. Reprogramming of cardiac fibroblasts by miR combo in vivo is associated with improved cardiac function following myocardial infarction. However, the efficiency of direct reprogramming in vitro is relatively modest and new strategies beyond the traditional
It was found in process of developing this technology that a
Practical application
This technology is important first step towards the future use of
Laboratories
- Department of Biomedical Engineering, Duke University, Durham (USA)
- Mandel Center for Hypertension Research and Duke Cardiovascular Research Center, Department of Medicine, Duke University Medical Center, Durham, (USA)
Links
http://www.nature.com/articles/srep38815Publications
- Li, Y. «
Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs." 6 Sci Rep. (2016): 38815. - Bian, W. et al. «Robust
T-tubulation and maturation of cardiomyocytes usingtissue-engineered epicardial mimetics." 35 Biomaterials, (2014): 3819–3828. - Liau, B., Zhang, D. & Bursac, N. Functional cardiac tissue engineering. Regenerative medicine, (2012): 187–206.